2024-03-25 16:35:19 ET
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals: Moving To Maximize The Value Of Its Core Asset
- Lexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Do
- Lexicon Pharma: Inpefa's Early Clinical Benefits, Rehospitalization Data May Unlock Significant Value
- Lexicon stock slides 8% after rallying 30% in prior session
- Lexicon stock rallies 18% amid FDA update, $250M private placement
Read the full article on Seeking Alpha
For further details see:
Lexicon Pharmaceuticals files to sell 57.66M shares for holders